Levels of tissue inhibitor of matrix metalloproteinases type 1, matrix metalloproteinase type 7 and anthropometric parameters in practically healthy women and women with arterial hypertension in the older age group

Cover Page

Cite item

Full Text

Abstract

Multiple studies are currently, aimed at studying the mechanisms of the development of basic age-related pathologies, e.g., arterial hypertension (AH). We found no literature sources concerning associations between the levels of matrix metalloproteinase type 7 (MMP-7), tissue inhibitor of matrix metalloproteinases type (TIMP-1) and anthropometric data which could be useful for diagnosing age-associated, socially dependent diseases and metabolic disorders. The article presents the data on the state of proteolysis system and anthropometric data of 45 almost healthy women and 45 women with arterial hypertension (AH) aged from 59 to 74 years old. The levels of MMP-7 and TIMP-1 in blood serum were studied by sandwich-variant of ELISA test. The waist and neck volume were measured three times with a centimeter tape at an accuracy of 1 cm. Statistical processing of the obtained data was performed using analytical software IBM SPSS Statistics, v. 22.0. The results show some correlations between the levels of MMP-7 and TIMP-1, and the waist and neck sizes (WC). Lower levels of MMP-7 and TIMP-1 were registered in the group of practically healthy women as compared to the second (AH) study group (p < 0.01). Anthropometric data were not markedly diverse: the waist size in the group of healthy women was less than in AH group (p < 0.05), and values of neck volume did not differ significantly between the groups. When assessing the relationships in the group of practically healthy women, we recorded a direct significant correlation between the waist size and neck volume (r = 0.754, p < 0.0001), while in the group of women with AH this relationship was weaker (r = 0.5782, p < 0.0001). In addition, a similar correlation was found between MMP-7 and TIMP-1 levels in the both groups studied. In the group of healthy women this relationship was of medium strength (r = 0.657, p < 0.0001), whereas in the group of women with AH it was stronger (r = 0.720, p < 0.0001). The data obtained suggest the presence of metabolic disorders in the women with arterial hypertension and signs of proteolytic enzyme system disorders.

About the authors

Natalya S. Chepurnova

Pacific State Medical University

Author for correspondence.
Email: Dr.cns@yandex.ru
ORCID iD: 0000-0001-6642-1332

PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology

Russian Federation, 2, Ostryakov Avenue, Vladivostok, 690000

Sergey V. Knysh

Pacific State Medical University

Email: s.knysh@m.tgmu.ru

PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology

Russian Federation, 2, Ostryakov Avenue, Vladivostok, 690000

Alla V. Rudneva

Pacific State Medical University

Email: markev2010@mail.ru

Senior Laboratory Assistant, Department of Normal and Pathological Physiology

Russian Federation, 2, Ostryakov Avenue, Vladivostok, 690000

Viktoria V. Zdor

Pacific State Medical University

Email: victoria.zdor@mail.ru

PhD, MD (Medicine), Senior Research Associate

Russian Federation, 2, Ostryakov Avenue, Vladivostok, 690000

Elena V. Markelova

Pacific State Medical University

Email: markev2010@mail.ru

Senior Laboratory Assistant, Department of Normal and Pathological Physiology

Russian Federation, 2, Ostryakov Avenue, Vladivostok, 690000

Polina V. Romanjuk

Pacific State Medical University

Email: Dr.cns@yandex.ru

Student, Medical Faculty

Russian Federation, 2, Ostryakov Avenue, Vladivostok, 690000

Semyon I. Sayapin

Pacific State Medical University

Email: Dr.cns@yandex.ru

Student, Medical Faculty

Russian Federation, 2, Ostryakov Avenue, Vladivostok, 690000

References

  1. Гиоева З.М., Богданов А.Р., Залетова Т.С., Богданова А.А. Ожирение как фактор риска развития хронической сердечной недостаточности // Доктор.ру, 2017. № 10 (139). С. 21-25. [Gioeva Z.M., Bogdanov A.R., Zaletova T.S., Bogdanova A.A. Obesity as a risk factor for the development of chronic heart failure. Doctor.ru = Doctor.ru, 2017, no. 10 (139), pp. 21-25. (In Russ.)]
  2. Грачев Н.И., Красников В.Е., Турмова Е.П., Маркелова Е.В., Рублев В.Ю., Назаренко С.А. Анализ показателей матриксной металлопротеиназы-9, тканевого ингибитора матриксных металлопротеиназ 1-го типа и их комплекса у пациентов с острым инфарктом миокарда, подвергшихся чрескожным коронарным вмешательствам // Тихоокеанский медицинский журнал, 2018. № 4 (74). С. 45-48. [Grachev N.I., Krasnikov V.E., Turmova E.P., Markelova E.V., Rublev V.Yu, Nazarenko S.A. Аnalysis of matrix metalloproteinase-9, tape inhibitor of matrix metalloproteinase type 1 and their complex in patients with acute miocard infarction who have exposed high coronary interventions. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal, 2018, no. 4 (74), pp. 45-48. (In Russ.)]
  3. Закирова А.Н., Фаткуллина Е.З., Закирова Н.Э. Роль матриксных металлопротеиназ в развитии гипертрофии левого желудочка у пациенток с артериальной гипертонией и метаболическим синдромом // Рациональная фармакотерапия в кардиологии, 2014. № 10 (1). С. 37-42. [Zakirova A.N., Fatkullina E.Z., Zakirova N.E. Role of matrix metalloproteinase in the development of left venter hipertrophy in patients with arterial hypertonia and metabolic syndrome. Ratsionalnaya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology, 2014, no. 10 (1), pp. 37-42. (In Russ.)]
  4. Зюбанова И.В., Мордовин В.Ф., Фальковская А.Ю., Пекарский С.Е., Рипп Т.М., Личикаки В.А., Гусакова А.М., Баев А.Е. Динамика биохимических показателей сосудистого фиброза под влиянием ренальной денервации у больных резистентной артериальной гипертензией И.В. // Сибирский медицинский журнал, 2016. Т. 31, № 2. С. 18-22. [Zyubanova I.V., Mordovin V.F., Falkovskaya A.Yu., Pekarsky S.E., Ripp T.M., Lichikaki V.A., Gusakova A.M., Baev A.E. Dynamics of bioshemical indicators of vascular phibrosis under the impact of renal denervation in i.v. resistent arterial hypertenses. Sibirskiy meditsinskiy zhurnal = Siberian Medical Journal, 2016, Vol. 31, no. 2, pp. 18-22. (In Russ.)]
  5. Казакова Т.С., Нурмамедова Е. Э. Методы проведения антропометрических исследований с целью определения состояния физического здоровья // Медицина и здравоохранение: материалы V Междунар. науч. конф. (г. Казань, май 2017 г.). Казань: Бук, 2017. С. 1-4. [Kazakova Т.S., Nurmamedova E.E. Methods of anthropometric studies to determine the state of physical health. Medicine and Public Health: materials of the V Intern. scientific conf. (Kazan, May 2017). Kazan: Buk, 2017, pp. 1-4. (In Russ.)]
  6. Михин В.П., Осипова О.А., Воротынцева В.В., Перуцкий Д.Н., Головина Н.И. Содержание матриксных металлопротеиназ в крови больных артериальной гипертонией с высоким сердечно-сосудистым риском на фоне терапии статинами // Кардиоваскулярная терапия и профилактика, 2022. Т. 21, № 10, 3422. [Mikhin V.P., Osipova O.A., Vorotyntseva V.V., Perutsky D.N., Golovina N.I. Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention, 2022, Vol. 21, no. 10, 3422. (In Russ.)] doi: 10.15829/1728-8800-2022-3422.
  7. Фальковская А.Ю., Мордовин В.Ф., Пекарский С.Е., Рипп Т.М., Зюбанова И.В., Ситкова Е.С., Личикаки В.А., Манукян М.А., Суслова Т.Е., Гусакова А.М., Рябова Т.Р. Система матриксных металлопротеиназ у больных резистентной артериальной гипертензией, ассоциированной с сахарным диабетом 2 го типа: связь с состоянием почечного кровотока и функцией почек // Артериальная гипертензия, 2019. Т. 25, № 1. С. 34-45. [Falkovskaya A.Yu., Mordovin V.F., Pekarsky S.E., Ripp T.M., Zyubanova I.V., Sitkova E.S., Licikaki V.A., Manukyan M.A., Suslova T.E., Gusakova A.M., Ryabova T.R. Matrix metalloproteinase system in patients with resistant arterial hypertension associated with type 2 diabetes mellitus: relationship with the state of renal blood flow and renal function. Arterialnaya gipertenziya = Arterial Hypertensia, 2019, Vol. 25, no. 1, pp. 34-45. (In Russ.)]
  8. Grzechocińska B., Dąbrowski F.A, Sierdzinski J., Cyganek A., Wielgoś M.. The association between serum metalloproteinase concentration, obesity, and hormone levels in reproductive-aged wome. Endokrynol. Pol., 2019, Vol. 70, no. 1, pp. 49-56.

Copyright (c) 2023 Chepurnova N.S., Knysh S.V., Rudneva A.V., Zdor V.V., Markelova E.V., Romanjuk P.V., Sayapin S.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies